Skip to content

Evidence-Based Assessment of Tabkheer in the Management of Siman-e-Mufrat: A BMI and Biomarker-Driven Comparison Comparative clinical trial of Tabkheer (Full Body Steam) and Safoof Mohazil and Arq Zeera In Obesity(Siman-e-Muffrat)

Evidence-Based Assessment of Tabkheer in the Management of Siman-e-Mufrat: A BMI and Biomarker-Driven Comparison with Safoof-e-Mohazil and Arq-e-Zeera A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104135
Enrollment
25
Registered
2026-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories

Interventions

Intervention1: A powdered Unani polyherbal formulation, Safoof Muhazil with polyherbal Unani distillation water, Arq zeera : Safoof-e-Mohazil (powdered form) and Arq-e-Zeera (distillate) in patients o

Sponsors

Regional Research Institute of Unani Medicine Srinagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with Body Mass Index (BMI) between 30 and 3.9 kilogram per square meter Subjects with abdominal obesity defined as waist circumference greater than 102 cm in men and greater than 88 cm in women. Patients willing to participate voluntarily are able to provide written informed consent and ready to comply with the study protocol and follow-up schedule.

Exclusion criteria

Exclusion criteria: Non-cooperative patient Patients below 18 years and above 60 years. BMI greater than 40 kilogram per square metre Patients who fail to give written consent. Pregnant Patients with DM Cardiovascular diseases

Design outcomes

Primary

MeasureTime frame
Change in BMI from baseline up to 4week,8week and 12 week Change in waist circumference from baseline up to 4week,8week and 12 week.Timepoint: BMI and waist circumference will be assessed at 4week,8week and 12 week

Secondary

MeasureTime frame
Change in BiomarkersTimepoint: 3 Months

Countries

India

Contacts

Public ContactDr Arjumand Shah

RRIUM, Srinagar

dr.arjumandshah111@gmail.com07006180746

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026